PHARMA RATES GMP INITIATIVES; DISPUTE RESOLUTION TEST OPENS

Executive Briefing Series
KEYWORDS Guidances
A A

Drugmakers are letting the FDA know they see some shortcomings in the latest stage of its current Good Manufacturing Practice (cGMP) initiative, in the hopes the agency will incorporate those suggestions in final versions of the draft guidances it issued last fall.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00